Viewing Study NCT02242266


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2026-02-22 @ 7:22 PM
Study NCT ID: NCT02242266
Status: COMPLETED
Last Update Posted: 2023-12-01
First Post: 2014-09-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics and Safety Comparison of Tiotropium Inhalation Powder Administered as the Bromide Salt From Hard Polyethylene Capsule Via the HandiHaler® 2 and Spiriva® HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: Boehringer Ingelheim
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 1184.9
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators